DNLI logo

Denali Therapeutics Inc. (DNLI) CAPEX

annual CAPEX:

$15.91M+$2.97M(+22.98%)
December 31, 2024

Summary

  • As of today (September 10, 2025), DNLI annual capital expenditures is $15.91 million, with the most recent change of +$2.97 million (+22.98%) on December 31, 2024.
  • During the last 3 years, DNLI annual CAPEX has risen by +$7.41 million (+87.20%).
  • DNLI annual CAPEX is now -11.20% below its all-time high of $17.92 million, reached on December 31, 2019.

Performance

DNLI CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDNLIcash flow metrics

quarterly CAPEX:

$4.28M-$800.00K(-15.75%)
June 30, 2025

Summary

  • As of today (September 10, 2025), DNLI quarterly capital expenditures is $4.28 million, with the most recent change of -$800.00 thousand (-15.75%) on June 30, 2025.
  • Over the past year, DNLI quarterly CAPEX has dropped by -$508.00 thousand (-10.61%).
  • DNLI quarterly CAPEX is now -58.35% below its all-time high of $10.27 million, reached on June 30, 2019.

Performance

DNLI quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDNLIcash flow metrics

TTM CAPEX:

$18.33M-$508.00K(-2.70%)
June 30, 2025

Summary

  • As of today (September 10, 2025), DNLI TTM capital expenditures is $18.33 million, with the most recent change of -$508.00 thousand (-2.70%) on June 30, 2025.
  • Over the past year, DNLI TTM CAPEX has increased by +$7.09 million (+63.11%).
  • DNLI TTM CAPEX is now -6.16% below its all-time high of $19.54 million, reached on June 30, 2023.

Performance

DNLI TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDNLIcash flow metrics

DNLI CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+23.0%-10.6%+63.1%
3 y3 years+87.2%+47.9%+54.5%
5 y5 years-11.2%+1258.1%+169.0%

DNLI CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-10.8%+87.2%-29.3%+106.9%-6.2%+63.1%
5 y5-year-11.2%+414.1%-29.3%+1258.1%-6.2%+492.3%
alltimeall time-11.2%+453.5%-58.4%+1258.1%-6.2%+1611.7%

DNLI CAPEX History

DateAnnualQuarterlyTTM
Jun 2025
-
$4.28M(-15.8%)
$18.33M(-2.7%)
Mar 2025
-
$5.08M(-0.3%)
$18.84M(+18.4%)
Dec 2024
$15.91M(+23.0%)
$5.09M(+31.1%)
$15.91M(+21.9%)
Sep 2024
-
$3.88M(-18.8%)
$13.05M(+16.2%)
Jun 2024
-
$4.79M(+122.6%)
$11.24M(-8.6%)
Mar 2024
-
$2.15M(-3.8%)
$12.30M(-4.9%)
Dec 2023
$12.94M(-27.4%)
$2.23M(+8.1%)
$12.94M(-16.8%)
Sep 2023
-
$2.07M(-64.6%)
$15.55M(-20.4%)
Jun 2023
-
$5.85M(+110.0%)
$19.54M(+17.8%)
Mar 2023
-
$2.79M(-42.5%)
$16.58M(-7.0%)
Dec 2022
$17.83M(+109.8%)
$4.85M(-19.9%)
$17.83M(+11.2%)
Sep 2022
-
$6.05M(+109.1%)
$16.04M(+35.2%)
Jun 2022
-
$2.89M(-28.4%)
$11.86M(+21.8%)
Mar 2022
-
$4.04M(+32.4%)
$9.74M(+14.6%)
Dec 2021
$8.50M
$3.05M(+62.8%)
$8.50M(+28.0%)
Sep 2021
-
$1.88M(+142.9%)
$6.64M(+21.4%)
DateAnnualQuarterlyTTM
Jun 2021
-
$772.00K(-72.4%)
$5.47M(+9.1%)
Mar 2021
-
$2.80M(+134.3%)
$5.02M(+62.1%)
Dec 2020
$3.10M(-82.7%)
$1.20M(+69.3%)
$3.10M(-33.8%)
Sep 2020
-
$706.00K(+124.1%)
$4.67M(-31.4%)
Jun 2020
-
$315.00K(-64.2%)
$6.81M(-59.4%)
Mar 2020
-
$879.00K(-68.3%)
$16.77M(-6.4%)
Dec 2019
$17.92M(+428.1%)
$2.77M(-2.6%)
$17.92M(+8.1%)
Sep 2019
-
$2.85M(-72.3%)
$16.58M(+13.7%)
Jun 2019
-
$10.27M(+406.5%)
$14.58M(+198.6%)
Mar 2019
-
$2.03M(+41.1%)
$4.88M(+43.9%)
Dec 2018
$3.39M(+18.0%)
$1.44M(+69.7%)
$3.39M(+12.1%)
Sep 2018
-
$847.00K(+48.1%)
$3.03M(+38.9%)
Jun 2018
-
$572.00K(+6.5%)
$2.18M(+35.6%)
Mar 2018
-
$537.00K(-49.9%)
$1.61M(+50.1%)
Dec 2017
$2.88M(-53.1%)
$1.07M(-53.7%)
$1.07M(-53.7%)
Dec 2016
$6.13M(+100.3%)
$2.31M
$2.31M
Dec 2015
$3.06M
-
-

FAQ

  • What is Denali Therapeutics Inc. annual capital expenditures?
  • What is the all time high annual CAPEX for Denali Therapeutics Inc.?
  • What is Denali Therapeutics Inc. annual CAPEX year-on-year change?
  • What is Denali Therapeutics Inc. quarterly capital expenditures?
  • What is the all time high quarterly CAPEX for Denali Therapeutics Inc.?
  • What is Denali Therapeutics Inc. quarterly CAPEX year-on-year change?
  • What is Denali Therapeutics Inc. TTM capital expenditures?
  • What is the all time high TTM CAPEX for Denali Therapeutics Inc.?
  • What is Denali Therapeutics Inc. TTM CAPEX year-on-year change?

What is Denali Therapeutics Inc. annual capital expenditures?

The current annual CAPEX of DNLI is $15.91M

What is the all time high annual CAPEX for Denali Therapeutics Inc.?

Denali Therapeutics Inc. all-time high annual capital expenditures is $17.92M

What is Denali Therapeutics Inc. annual CAPEX year-on-year change?

Over the past year, DNLI annual capital expenditures has changed by +$2.97M (+22.98%)

What is Denali Therapeutics Inc. quarterly capital expenditures?

The current quarterly CAPEX of DNLI is $4.28M

What is the all time high quarterly CAPEX for Denali Therapeutics Inc.?

Denali Therapeutics Inc. all-time high quarterly capital expenditures is $10.27M

What is Denali Therapeutics Inc. quarterly CAPEX year-on-year change?

Over the past year, DNLI quarterly capital expenditures has changed by -$508.00K (-10.61%)

What is Denali Therapeutics Inc. TTM capital expenditures?

The current TTM CAPEX of DNLI is $18.33M

What is the all time high TTM CAPEX for Denali Therapeutics Inc.?

Denali Therapeutics Inc. all-time high TTM capital expenditures is $19.54M

What is Denali Therapeutics Inc. TTM CAPEX year-on-year change?

Over the past year, DNLI TTM capital expenditures has changed by +$7.09M (+63.11%)
On this page